首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Acute Normovolemic Hemodilution Effects on Perioperative Coagulation in Elderly Patients Undergoing Hepatic Carcinectomy
【24h】

Acute Normovolemic Hemodilution Effects on Perioperative Coagulation in Elderly Patients Undergoing Hepatic Carcinectomy

机译:急性正血液稀释对老年人肝癌切除术围手术期凝血的影响

获取原文
           

摘要

Background: Acute normovolemic hemodilution (ANH) has been widely used to prevent the massive bloodloss during hepatic carcinoma. The influences of ANH on coagulation function are still controversy, especiallyin elderly patients. The study observed ANH effects on coagulation function and fibrinolysis in elderly patientsundergoing the disease. Materials and Methods: Thirty elderly patients (aged 60-70 yr) with liver cancer (ASAⅠ or Ⅱ) taken hepatic carcinectomy from February 2007 to February 2008 were randomly divided into ANHgroup (n=15) and control group (n=15). After tracheal intubation, patients in ANH group and control groupwere infused with 6% hydroxyethyl starch (130/0.4) and Ringer’s solution, respectively. Blood samples weredrawn from patients in both groups at five different time points: before anesthesia induction (T1), 30 min afterANH (T2), 1 h after start of operation (T3), immediately after operation (T4), and 24 h after operation (T5).Then coagulation function, soluble fibrin monomer complex (SFMC), prothrombin fragment (F1+2), and plateletmembrane glycoprotein (CD62P and activated GP IIb/GP IIIa) were measured. Results: The perioperativeblood loss and allogeneic blood transfusion were recorded during the surgery. The perioperative blood loss wasnot significantly different between two groups (p>0.05), but the volume of allogeneic blood transfusion in ANHgroup was significantly less than in control group (350.0±70.7) mL vs. (457.0±181.3) mL (p 0.05). SFMC andF1+2 increased in both groups, but were not statistically significant. PAC-1-positive cells and CD62P expressionsin patients of ANH group were significantly lower than those at T1 (p 0.05). Conclusions:ANH has no obvious impact on fibrinolysis and coagulation function in elderly patients undergoing resection ofliver cancer. The study suggested that ANH is safe to use in elderly patients and it could reduce allogeneic bloodtransfusion.
机译:背景:急性降血常规血液稀释(ANH)已被广泛用于预防肝癌期间大量失血。 ANH对凝血功能的影响仍存在争议,尤其是在老年患者中。该研究观察到ANH对正在接受该疾病的老年患者的凝血功能和纤维蛋白溶解的影响。材料与方法:2007年2月至2008年2月,对30例年龄在60-70岁的60岁至70岁肝癌患者(ASAⅠ或Ⅱ)行肝癌切除术,随机分为ANH组(n = 15)和对照组(n = 15)。气管插管后,分别向ANH组和对照组的患者输注6%羟乙基淀粉(130 / 0.4)和林格氏液。在五个不同的时间点从两组患者中抽取血样:麻醉诱导前(T1),ANH后30分钟(T2),手术后1小时(T3),手术后立即(T4)和手术后24小时(T5)。然后测量凝血功能,可溶性纤维蛋白单体复合物(SFMC),凝血酶原片段(F1 + 2)和血小板膜糖蛋白(CD62P和活化的GP IIb / GP IIIa)。结果:术中记录围手术期失血和异体输血。两组围手术期失血量无显着差异(p> 0.05),但ANH组同种异体输血量显着小于对照组(350.0±70.7)mL与(457.0±181.3)mL(p 0.05) 。两组的SFMC和F1 + 2均升高,但无统计学意义。 ANH组患者的PAC-1阳性细胞和CD62P表达明显低于T1组(p 0.05)。结论:ANH对老年肝癌切除术的纤溶和凝血功能无明显影响。研究表明,ANH在老年患者中安全使用,并且可以减少异体输血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号